Cyclosporin A Reverses Chemoresistance in Patients With Gynecologic Malignancies
Multidrug resistance is a major obstacle in successful systemic therapy of gynecologic malignancies. The objectives of this study are to evaluate the activity of cyclosporin A used to overcome drug resistance in a variety of gynecologic malignancies. Forty women (29 with ovarian cancer, 7 with uteri...
Main Authors: | Anil K. Sood, Joel I. Sorosky, Robert C. Squatrito, Jeffrey S. Skilling, Barrie Anderson, Richard E. Buller |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1999-06-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558699800517 |
Similar Items
-
Cyclosporine
by: Nahide Onsun
Published: (2022-04-01) -
Absence of clinically relevant effect of caspofungin on cyclosporin pharmacokinetics
by: C Sanz-Rodriguez, et al.
Published: (2005-11-01) -
Comparative Evaluation of Tacrolimus and Cyclosporine in Patients with Steroid-resistant Nephrotic Syndrome: A Systematic Review and Meta-analysis
by: Yalda Ravanshad, et al.
Published: (2019-09-01) -
Cyclosporine therapeutic window evaluation by Chebyshev's inequality method in kidney recipients
by: Aurelija Noreikaitė, et al.
Published: (2014-01-01) -
Cyclosporin-A induced Posterior Reversible Encephalopathy Syndrome
by: Saeed Bassam, et al.
Published: (2008-01-01)